Web Desc
Cancer Epigenetics: New Mechanisms, New Therapies
Organizer(s): François Fuks and Anne Brunet
Date: February 10 - 14, 2018
Location: Beaver Run Resort, Breckenridge, CO, USA
Sponsored by Cancer Research UK, Cell Research, Incyte Corporation, Merck & Co., Inc., Novartis Institutes for BioMedical Research, Pfizer Inc. and Roche
For important information on the coronavirus, please click here
Summary of Meeting:
The field of epigenetics has recently emerged as an essential component of oncology research, with altered epigenetic modifications considered to be critical hallmarks of cancers. Unlike mutations, epigenetic aberrations are reversible and as a result, epigenetic therapies hold great promise as anti-cancer agents. For these novel therapies to succeed, a key challenge is to fully understand the nature and the mechanisms that lead to epigenetic changes in cancer. Another essential challenge is to make sense of the avalanche of data flowing from increasingly powerful 'omics-based' technologies. Despite these challenges, never has the potential for scientific and clinical breakthroughs in this field been greater. Bringing together both the academic and the pharmaceutical communities, this Keystone Symposia conference will focus on: 1) The newest findings concerning the mechanisms by which epigenetic pathways are established and maintained in normal and stem cells, and how these go awry during aging and cancer, with a special emphasis on histone modifications, chromatin remodeling and the unexpected increased number of DNA modifications ((hydroxy)methylcytosine and methyladenine); 2) The growing roles of noncoding RNAs in cancer and the emergence of the new and exciting realm of RNA epigenetics; 3) Use of new omics technologies to interrogate altered epigenetic landscapes in tumors and assess their clinical implications; and 4) Novel and promising therapeutic drugs aimed at reversing specific epigenetic alterations. Ultimately, the meeting will provide great opportunities for senior and junior scientists to meet the leaders in the field from both academia and industry, hence forging exciting interdisciplinary interactions and creating potential new collaborations in the burgeoning area of cancer epigenetics.
Scholarship Deadline: October 10 2017
Discounted Abstract Deadline: October 10 2017
Abstract Deadline: November 8 2017
Discounted Registration Deadline: December 12 2017
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.


Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Cancer Research UKCell ResearchIncyte CorporationMerck & Co., Inc.Novartis Institutes for BioMedical ResearchPfizer Inc.Roche
We gratefully acknowledge additional support from these exhibitors at this conference:
EpiCypher
We gratefully acknowledge additional support for this conference from:
Abcam plc
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Ionis Pharmaceuticals, Inc.

Merck & Co., Inc.

Novartis Institutes for BioMedical Research
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1 R13 CA224772-01
Funding for this conference was made possible (in part) by 1 R13 CA224772-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Saturday, February 10 | 4:00PM - 8:00PM
Arrival and Registration
Room: Foyer


Saturday, February 10 | 6:00PM - 8:00PM
Welcome Mixer
Room: Foyer
No registration fees are used to fund alcohol served at this function.

Sunday, February 11 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Sunday, February 11 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Colorado Ballroom

Speaker 1 of 3
* François Fuks, Université Libre de Bruxelles, Belgium

Sunday, February 11 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Colorado Ballroom

Speaker 2 of 3
* Anne Brunet, Stanford University, USA

Sunday, February 11 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Colorado Ballroom

Speaker 3 of 3
Tony Kouzarides, University of Cambridge, UK
Modifications of RNA: Their Function and Role in Cancer

Sunday, February 11 | 9:00AM - 11:30AM
Epigenetic Mechanisms and Cancer
Room: Colorado Ballroom

Speaker 1 of 7
* Anne Brunet, Stanford University, USA

Sunday, February 11 | 9:00AM - 11:30AM
Epigenetic Mechanisms and Cancer
Room: Colorado Ballroom

Speaker 2 of 7
Geneviève Almouzni, Centre National de la Recherche Scientifique, France
Chromatin Determinants of Centromeric Identity and their Deregulation in Cancer

Sunday, February 11 | 9:00AM - 11:30AM
Epigenetic Mechanisms and Cancer
Room: Colorado Ballroom

Speaker 3 of 7
Adrian P. Bracken, Trinity College Dublin, Ireland
Short Talk: A New Family of Vertebrate-Specific Polycombs Balance PRC2 Subtype Activities

Sunday, February 11 | 9:00AM - 11:30AM
Epigenetic Mechanisms and Cancer
Room: Colorado Ballroom


Coffee Break

Sunday, February 11 | 9:00AM - 11:30AM
Epigenetic Mechanisms and Cancer
Room: Colorado Ballroom

Speaker 5 of 7
François Fuks, Université Libre de Bruxelles, Belgium
Transcriptome-Wide Distribution and Function of RNA Modifications in Cancer


Sunday, February 11 | 9:00AM - 11:30AM
Epigenetic Mechanisms and Cancer
Room: Colorado Ballroom

Speaker 6 of 7
Panagiotis Ntziachristos, Northwestern University, USA
Short Talk: Active Deubiquitination as a Molecular Rheostat Controlling Resistance to Therapy in Acute Leukemia

Sunday, February 11 | 9:00AM - 11:30AM
Epigenetic Mechanisms and Cancer
Room: Colorado Ballroom

Speaker 7 of 7
Shelley L. Berger, University of Pennsylvania, USA
Epigenetic Pathways as Targets in Human Cancer

Sunday, February 11 | 11:30AM - 5:00PM
On Own for Lunch


Sunday, February 11 | 11:30AM - 1:00PM
Poster Setup
Room: Breckenridge Ballroom


Sunday, February 11 | 1:00PM - 10:00PM
Poster Viewing
Room: Breckenridge Ballroom


Sunday, February 11 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Sunday, February 11 | 5:00PM - 7:30PM
Chromatin Dysregulations in Cancer
Room: Colorado Ballroom

Speaker 1 of 6
* Johnathan R. Whetstine, Fox Chase Cancer Center, USA

Sunday, February 11 | 5:00PM - 7:30PM
Chromatin Dysregulations in Cancer
Room: Colorado Ballroom

Speaker 2 of 6
Luciano Di Croce, CRG - Center for Genomic Regulation, Spain
Role of Polycomb and MLL Complexes in Nuclear Architecture and Gene Regulation

Sunday, February 11 | 5:00PM - 7:30PM
Chromatin Dysregulations in Cancer
Room: Colorado Ballroom

Speaker 3 of 6
Cigall Kadoch, Dana-Farber Cancer Institute, Harvard Medical School, USA
BAF Complex Structure and Function in Human Cancer

Sunday, February 11 | 5:00PM - 7:30PM
Chromatin Dysregulations in Cancer
Room: Colorado Ballroom

Speaker 4 of 6
Tom Owen-Hughes, University of Dundee, Scotland
Short Talk: Variation in the Protein Composition of SWI/SNF Chromatin Remodeling Complexes in Clear Cell Renal Carcinoma

Sunday, February 11 | 5:00PM - 7:30PM
Chromatin Dysregulations in Cancer
Room: Colorado Ballroom

Speaker 5 of 6
Ozgur Oksuz, New York University School of Medicine, USA
Capturing the Onset of Polycomb Domain Formation

Sunday, February 11 | 5:00PM - 7:30PM
Chromatin Dysregulations in Cancer
Room: Colorado Ballroom

Speaker 6 of 6
William J. Greenleaf, Stanford University, USA
ATAC-ing Gene Regulation in Cancer and Development

Sunday, February 11 | 7:30PM - 8:30PM
Social Hour with Lite Bites
Room: Breckenridge Ballroom
No registration fees are used to fund alcohol served at this function.

Sunday, February 11 | 7:30PM - 10:00PM
Poster Session 1
Room: Breckenridge Ballroom


Monday, February 12 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Monday, February 12 | 8:00AM - 11:15AM
Emergence of Epitranscriptomics
Room: Colorado Ballroom

Speaker 1 of 8
* Cigall Kadoch, Dana-Farber Cancer Institute, Harvard Medical School, USA

Monday, February 12 | 8:00AM - 11:15AM
Emergence of Epitranscriptomics
Room: Colorado Ballroom

Speaker 2 of 8
Lu Wang, Northwestern University, USA
Resetting the Epigenetic Balance of Polycomb/COMPASS Function for Cancer Therapy

Monday, February 12 | 8:00AM - 11:15AM
Emergence of Epitranscriptomics
Room: Colorado Ballroom

Speaker 3 of 8
Chuan He, University of Chicago, USA
Aberrant RNA Methylation in Human Cancers

Monday, February 12 | 8:00AM - 11:15AM
Emergence of Epitranscriptomics
Room: Colorado Ballroom

Speaker 4 of 8
Ulrike Litzenburger, Stanford University, USA
Short Talk: Direct Linkage of Cancer Cell Epigenomic State with Phenotype using Multi-Index Single-Cell ATAC-Seq

Monday, February 12 | 8:00AM - 11:15AM
Emergence of Epitranscriptomics
Room: Colorado Ballroom


Coffee Break

Monday, February 12 | 8:00AM - 11:15AM
Emergence of Epitranscriptomics
Room: Colorado Ballroom

Speaker 6 of 8
Gideon Rechavi, Tel Aviv University, Israel
Cancer Epitranscriptomics

Monday, February 12 | 8:00AM - 11:15AM
Emergence of Epitranscriptomics
Room: Colorado Ballroom

Speaker 7 of 8
Brian J. Abraham, St. Jude Children's Research Hospital, USA
Short Talk: Three-Dimensional Gene Regulatory Landscapes in Normal and Cancer Cells

Monday, February 12 | 8:00AM - 11:15AM
Emergence of Epitranscriptomics
Room: Colorado Ballroom

Speaker 8 of 8
Gerald R. Crabtree, Stanford University, USA
Pathogenic Mechanisms in the Opposition of BAF(mSWI/SNF) and Polycomb in Human Cancer

Monday, February 12 | 11:15AM - 5:00PM
On Own for Lunch


Monday, February 12 | 11:15AM - 1:00PM
Poster Setup
Room: Breckenridge Ballroom


Monday, February 12 | 1:00PM - 10:00PM
Poster Viewing
Room: Breckenridge Ballroom


Monday, February 12 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Monday, February 12 | 5:00PM - 7:00PM
Chromatin Assembly, Stem Cells and Aging
Room: Colorado Ballroom

Speaker 1 of 5
* Karen Adelman, Harvard Medical School, USA

Monday, February 12 | 5:00PM - 7:00PM
Chromatin Assembly, Stem Cells and Aging
Room: Colorado Ballroom

Speaker 2 of 5
Robert E. Kingston, Massachusetts General Hospital, USA
Nucleosome Compaction and Polycomb-Group Repressive Function during Development


Monday, February 12 | 5:00PM - 7:00PM
Chromatin Assembly, Stem Cells and Aging
Room: Colorado Ballroom

Speaker 3 of 5
Johnathan R. Whetstine, Fox Chase Cancer Center, USA
Epigenetics as a Gatekeeper to DNA Amplification

Monday, February 12 | 5:00PM - 7:00PM
Chromatin Assembly, Stem Cells and Aging
Room: Colorado Ballroom

Speaker 4 of 5
Ernesto Guccione, Institute of Molecular and Cell Biology, Singapore
Short Talk: Investigating the Function of PRDM Proteins in Stem Cells and Cancer

Monday, February 12 | 5:00PM - 7:00PM
Chromatin Assembly, Stem Cells and Aging
Room: Colorado Ballroom

Speaker 5 of 5
Anne Brunet, Stanford University, USA
Epigenetic and Metabolic Regulation of Aging and Rejuvenation


Monday, February 12 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Breckenridge Ballroom
No registration fees are used to fund alcohol served at this function.

Monday, February 12 | 7:30PM - 10:00PM
Poster Session 2
Room: Breckenridge Ballroom


Tuesday, February 13 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Tuesday, February 13 | 8:00AM - 11:15AM
DNA (de)Methylation Dynamics and Cancer
Room: Colorado Ballroom

Speaker 1 of 8
* Kornelia Polyak, Dana-Farber Cancer Institute, Harvard Medical School, USA

Tuesday, February 13 | 8:00AM - 11:15AM
DNA (de)Methylation Dynamics and Cancer
Room: Colorado Ballroom

Speaker 2 of 8
Stephen B. Baylin, Johns Hopkins University School of Medicine, USA
DNA Methylation in Stem Cell and Cancer

Tuesday, February 13 | 8:00AM - 11:15AM
DNA (de)Methylation Dynamics and Cancer
Room: Colorado Ballroom

Speaker 3 of 8
Luisa Cimmino, New York University, USA
Short Talk: Restoration of TET Function as a Therapeutic Strategy in Leukemia

Tuesday, February 13 | 8:00AM - 11:15AM
DNA (de)Methylation Dynamics and Cancer
Room: Colorado Ballroom

Speaker 4 of 8
Peter A. Jones, Van Andel Research Institute, USA
Targeting Endogenous Retroviruses for Therapy

Tuesday, February 13 | 8:00AM - 11:15AM
DNA (de)Methylation Dynamics and Cancer
Room: Colorado Ballroom


Coffee Break

Tuesday, February 13 | 8:00AM - 11:15AM
DNA (de)Methylation Dynamics and Cancer
Room: Colorado Ballroom

Speaker 6 of 8
Salvador Aznar Benitah, ICREA and Institute for Research in Biomedicine, Spain
Epigenetic Mechanisms in Adult Stem Cell Function, and their Impact over Mutational Burden of Cancer Stem Cells


Tuesday, February 13 | 8:00AM - 11:15AM
DNA (de)Methylation Dynamics and Cancer
Room: Colorado Ballroom

Speaker 7 of 8
Timothy C. Hallstrom, University of Minnesota, USA
Short Talk: UHRF2 Control of 5hmC Homeostasis and Differentiation in Retinal Progenitor Cells

Tuesday, February 13 | 8:00AM - 11:15AM
DNA (de)Methylation Dynamics and Cancer
Room: Colorado Ballroom

Speaker 8 of 8
Karen Adelman, Harvard Medical School, USA
Probing Transcription Regulation at Enhancers

Tuesday, February 13 | 11:15AM - 5:00PM
On Own for Lunch


Tuesday, February 13 | 11:15AM - 1:00PM
Poster Setup
Room: Breckenridge Ballroom


Tuesday, February 13 | 1:00PM - 10:00PM
Poster Viewing
Room: Breckenridge Ballroom


Tuesday, February 13 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Tuesday, February 13 | 5:00PM - 7:00PM
Connecting Noncoding RNAs and Cancer
Room: Colorado Ballroom

Speaker 1 of 5
* Salvador Aznar Benitah, ICREA and Institute for Research in Biomedicine, Spain

Tuesday, February 13 | 5:00PM - 7:00PM
Connecting Noncoding RNAs and Cancer
Room: Colorado Ballroom

Speaker 2 of 5
John L. Rinn, University of Colorado Boulder, USA
A Conserved TAD Boundary Organization at the Firre lncRNA Locus Is Resistant to Loss of Numerous CTCF Binding Sites

Tuesday, February 13 | 5:00PM - 7:00PM
Connecting Noncoding RNAs and Cancer
Room: Colorado Ballroom

Speaker 3 of 5
Chris Marine, VIB-KU Leuven, Belgium
(Patho-)Physiological Functions of the lncRNA NEAT1

Tuesday, February 13 | 5:00PM - 7:00PM
Connecting Noncoding RNAs and Cancer
Room: Colorado Ballroom

Speaker 4 of 5
Yotam Drier, MGH and Harvard Medical School, USA
Short Talk: Epigenetic Inhibition of CTCF Insulation in Cancer

Tuesday, February 13 | 5:00PM - 7:00PM
Connecting Noncoding RNAs and Cancer
Room: Colorado Ballroom

Speaker 5 of 5
Robert A. Martienssen, Cold Spring Harbor Laboratory, USA
Replication-Coupled Silencing and Spreading with RNAi

Tuesday, February 13 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Breckenridge Ballroom
No registration fees are used to fund alcohol served at this function.

Tuesday, February 13 | 7:30PM - 10:00PM
Poster Session 3
Room: Breckenridge Ballroom


Wednesday, February 14 | 7:00AM - 8:00AM
Breakfast
Room: Summit Gallery


Wednesday, February 14 | 8:00AM - 11:15AM
Novel Therapeutic Discoveries in Epigenetics I
Room: Colorado Ballroom

Speaker 1 of 8
* John L. Rinn, University of Colorado Boulder, USA

Wednesday, February 14 | 8:00AM - 11:15AM
Novel Therapeutic Discoveries in Epigenetics I
Room: Colorado Ballroom

Speaker 2 of 8
Mark A. Dawson, Peter MacCallum Cancer Centre, Australia
Molecular Mechanisms Governing Sensitivity and Resistance to Epigenetic Therapies

Wednesday, February 14 | 8:00AM - 11:15AM
Novel Therapeutic Discoveries in Epigenetics I
Room: Colorado Ballroom

Speaker 3 of 8
Danette L. Daniels, Promega Corporation, USA
Short Talk: Understanding the Functional Pathway of BET Family Degradation Compounds

Wednesday, February 14 | 8:00AM - 11:15AM
Novel Therapeutic Discoveries in Epigenetics I
Room: Colorado Ballroom

Speaker 4 of 8
Kornelia Polyak, Dana-Farber Cancer Institute, Harvard Medical School, USA
KDM5B Links Cellular Transcriptome Heterogeneity to Therapy Resistance


Wednesday, February 14 | 8:00AM - 11:15AM
Novel Therapeutic Discoveries in Epigenetics I
Room: Colorado Ballroom


Coffee Break

Wednesday, February 14 | 8:00AM - 11:15AM
Novel Therapeutic Discoveries in Epigenetics I
Room: Colorado Ballroom

Speaker 6 of 8
Robert MacLeod, Ionis Pharmaceuticals, Inc., USA
Next Generation Antisense Oligonucleotides as Therapeutic Inhibitors of LncRNAs for the Treatment of Cancer

Wednesday, February 14 | 8:00AM - 11:15AM
Novel Therapeutic Discoveries in Epigenetics I
Room: Colorado Ballroom

Speaker 7 of 8
Allison E. Drew, Epizyme, USA
Short Talk: Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma

Wednesday, February 14 | 8:00AM - 11:15AM
Novel Therapeutic Discoveries in Epigenetics I
Room: Colorado Ballroom

Speaker 8 of 8
Ronan C. O'Hagan, Merck Research Laboratories, USA
Epigenetics and Immune Modulation in Cancer

Wednesday, February 14 | 11:15AM - 5:00PM
On Own for Lunch


Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 1 of 10
* Tom Owen-Hughes, University of Dundee, Scotland

Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 2 of 10
Giovanni Ciriello, University of Lausanne, Switzerland
The Landscape of Aberrant DNA Methylation across Human Cancers

Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 3 of 10
Robert M. Witwicki, Dana-Farber Cancer Institute, USA
Novel Epigenetic Dependencies of Human Cancers

Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 4 of 10
Noa Furth, Weizmann Institute of Science, Israel
Rewiring of Tumor Suppressors Networks: LATS Kinases and p53

Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 5 of 10
Sandra Schick, CeMM GmbH, Austria
Loss of Specific Mammalian BAF Subunits Causes Global Changes in Chromatin Accessibility

Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 6 of 10
Molly Kingsley, University of Colorado, USA
The Role of H3K79 Methylation in IDH Mutant AML

Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 7 of 10
Elisa Oricchio, École Polytechnique Fédérale de Lausanne, Switzerland
Oncogenic Mutation of EZH2 Inactivates Tumor- Suppressive TADs to Promote Lymphomagenesis

Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 8 of 10
David I. Remillard, Harvard University, USA
Targeted Degradation of BRD9 as a Therapeutic Strategy in BAF-Dependent Cancers

Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 9 of 10
Lingyan Jin, Genentech, Inc., USA
Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer

Wednesday, February 14 | 2:00PM - 4:30PM
Workshop: Epigenetic Pathways and Cancer
Room: Colorado Ballroom

Speaker 10 of 10
Beth Zucconi, Harvard Medical School, USA
Modulation of p300/CBP Activity by Small Molecules

Wednesday, February 14 | 4:30PM - 5:00PM
Coffee Available
Room: Foyer


Wednesday, February 14 | 5:00PM - 6:45PM
Novel Therapeutic Discoveries in Epigenetics II
Room: Colorado Ballroom

Speaker 1 of 4
* Mark A. Dawson, Peter MacCallum Cancer Centre, Australia

Wednesday, February 14 | 5:00PM - 6:45PM
Novel Therapeutic Discoveries in Epigenetics II
Room: Colorado Ballroom

Speaker 2 of 4
Myriem Boufraqech, NCI, National Institutes of Health, USA
Targeting the Epigenome in Endocrine Cancers

Wednesday, February 14 | 5:00PM - 6:45PM
Novel Therapeutic Discoveries in Epigenetics II
Room: Colorado Ballroom

Speaker 3 of 4
Rab K. Prinjha, GlaxoSmithKline, UK
Epigenetic Targets for the Treatment of Human Diseases

Wednesday, February 14 | 5:00PM - 6:45PM
Novel Therapeutic Discoveries in Epigenetics II
Room: Colorado Ballroom

Speaker 4 of 4
James E. Bradner, Novartis Institutes for BioMedical Research, USA
Targeted Degradation of Chromatin-Associated Transcription Factors

Wednesday, February 14 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Colorado Ballroom


Wednesday, February 14 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Breckenridge Ballroom
No registration fees are used to fund alcohol served at this function.

Wednesday, February 14 | 8:00PM - 11:00PM
Entertainment
Room: Breckenridge Ballroom
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Wednesday, February 14 | 8:00PM - 11:00PM
Cash Bar
Room: Breckenridge Ballroom


Thursday, February 15 | 10:24AM - 10:24AM
Departure


*Session Chair
†Invited, not yet responded.